How Biotech Startups Use Organoids for Drug Testing

Episode 60 of Biotech Business with Fexingo dives into organoids—miniature 3D organ models grown from stem cells that are reshaping drug testing. Lucas explains how a startup called Organome used colon organoids to screen a library of 50,000 compounds for inflammatory bowel disease, cutting preclinical timelines by 18 months. Luna questions whether these lab-grown tissues can truly mimic human physiology, and they discuss the recent FDA decision to accept organoid data as alternative to animal studies. This is a concrete look at how engineering biology is speeding up the long, expensive road to market for new therapies. #Organoids #BiotechStartups #DrugDiscovery #StemCells #Organome #IBD #FDA #PreclinicalTesting #3DCellCulture #PersonalizedMedicine #Business #Technology #LifeSciences #FexingoBusiness #BusinessPodcast #BiotechBusiness #StartupStrategy #DrugDevelopment Keep every episode free: buymeacoffee.com/fexingo